Margo Georgiadis is Co-Founder and CEO of Montai Therapeutics, a company pioneering at the intersection of technology, validated biology, and diverse, untapped human chemistry in pursuit of transformative medicines for chronic disease. Margo is also a CEO-Partner at Flagship Pioneering, the bioplatform innovation company behind more than 100 scientific ventures in human health and sustainability. Margo has dedicated her career to transforming products and services with data and technology to empower consumers to live better lives, and to deliver outsized growth and returns for investors. Prior to founding Montai, she held multiple senior leadership roles including President and CEO of Ancestry and President of Americas and Vice President of Global Operations at Google. She also is an experienced investor and worked at both General Catalyst and Synetro Group building next generation technology and healthcare platforms. Margo serves on the Boards of several market leaders and innovators including McDonald’s, Applovin, Handshake, Ro, Harbinger Health and the Parker Institute for Cancer Immunotherapy.